Life-threatening hyponatraemia and neurotoxicity during chemotherapy for Burkitt's lymphoma.
Osier
F H A
FH
Kenya Medical Research Institute, Centre for Geographic Medicine Research, Coast, Kilifi District Hospital, Paediatric Department, Kilifi. fosier@kilifi.mimcom.net
Berkley
J A
JA
Newton
C R J C
CR
D000970:Antineoplastic Agents / Q000009:adverse effects*; D018906:Antineoplastic Agents, Alkylating / Q000009:adverse effects; D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects; D002051:Burkitt Lymphoma / Q000188:drug therapy*; D002648:Child; D003520:Cyclophosphamide / Q000009:adverse effects; D004359:Drug Therapy, Combination; D006801:Humans; D007010:Hyponatremia / Q000139:chemically induced*; D007573:Jaw Neoplasms / Q000188:drug therapy*; D008297:Male; D020258:Neurotoxicity Syndromes / Q000209:etiology*; D014750:Vincristine / Q000009:adverse effects
D000970:Antineoplastic Agents; D018906:Antineoplastic Agents, Alkylating; D000972:Antineoplastic Agents, Phytogenic; D014750:Vincristine; D003520:Cyclophosphamide